Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/12543773

Cancer Res. 2003 Jan 15 63 2 277-81

Download in:

View as

General Info

PMID
12543773